Emerging trends in family history of breast cancer and associated risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 26, Issue 12, 2017, Pages 1753-1760

  Shiyanbola, Oyewale O ^a   Arao, Robert F ^b   Miglioretti, Diana L ^b,c   Sprague, Brian L ^d   Hampton, John M ^e   Stout, Natasha K ^f   Kerlikowske, Karla ^g   Braithwaite, Dejana ^g   Buist, Diana S M ^b   Egan, Kathleen M ^h   Newcomb, Polly A ⁱ   Trentham Dietz, Amy ^a,e  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b KAISER PERMANENTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF WISCONSIN   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

ⁱ USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; FIRST-DEGREE RELATIVE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; AGE; ANAMNESIS; BREAST TUMOR; COHORT ANALYSIS; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; INTRADUCTAL CARCINOMA; MASS SCREENING; MIDDLE AGED; PATHOLOGY; PROCEDURES; REGISTER; STATISTICS AND NUMERICAL DATA; TIME FACTOR; UNITED STATES;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MEDICAL HISTORY TAKING; MIDDLE AGED; NEOPLASM STAGING; PREVALENCE; REGISTRIES; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 85036642916     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-17-0531     Document Type: Article

References (54)

1. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;358:1389–99.
2. Tice JA, Miglioretti DL, Li CS, Vachon CM, Gard CC, Kerlikowske K. Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer. J Clin Oncol 2015;33:3137–43.
3. Kharazmi E, Chen T, Narod S, Sundquist K, Hemminki K. Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: a nationwide prospective cohort study. Breast Cancer Res Treat 2014;144:185–92.
4. Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, O'Meara ES, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med 2012;156:635–48.
5. Feuer EJ, Wun LM. How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach. Am J Epidemiol 1992;136:1423–36.
6. DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. Cancer J Clin 2014;64:52–62.
7. Glass AG, Lacey JV Jr., Carreon JD, Hoover RN. Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 2007; 99:1152–61.
8. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 2009;302:1685–92.
9. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, et al. SEER Cancer Statistics Review, 1975—2014 [Internet]. Bethesda, MD: National Cancer Institute; 2016. Available from: https://seer.cancer.gov/csr/1975_2014/.
10. van Luijt PA, Heijnsdijk EA, Fracheboud J, Overbeek LI, Broeders MJ, Wesseling J, et al. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening. Breast Cancer Res 2016;18:47.
11. Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002;94:1546–54.
12. Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA, et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. Am J Roentgenol 1997;169:1001–8.
13. Onega T, Goldman LE, Walker RL, Miglioretti DL, Buist DS, Taplin S, et al. Facility mammography volume in relation to breast cancer screening outcomes. J Med Screen 2016;23:31–7.
14. National Cancer Institute. Breast Cancer Surveillance Consortium: evaluating screening performance in practice [Internet]. Bethesda, MD: National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services; 2004.
15. Breast Cancer Surveillance Consortium. Data elements and questionnaires [Internet] Seattle, WA: BCSC Statistical Coordinating Center; 2017. Available from: http://www.bcsc-research.org/data/elements.html.
16. Newcomb PA, Trentham-Dietz A, Hampton JM, Egan KM, Titus-Ernstoff L, Warren Andersen S, et al. Late age at first full term birth is strongly associated with lobular breast cancer. Cancer 2011;117: 1946–56.
17. Sprague BL, Trentham-Dietz A, Newcomb PA, Titus-Ernstoff L, Hampton JM, Egan KM. Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2007;16:236–43.
18. Nichols HB, Trentham-Dietz A, Sprague BL, Hampton JM, Titus-Ernstoff L, Newcomb PA. Effects of birth order and maternal age on breast cancer risk: modification by whether women had been breast-fed. Epidemiology 2008;19:417–23.
19. Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA, editors. SEER Summary Staging Manual -2000: codes and coding instructions. Bethesda, MD: National Cancer Institute; 2001.
20. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Health People Statistical Notes, no. 20. Hyattsville, MD: National Center for Health Statistics. January 2001; 2001, pp. 1–10.
21. National Center for Health Statistics. Health, United States, 2014: with special feature on adults aged 55–64. Hyattsville, MD: National Center for Health Statistics; 2015.
22. White A, Thompson TD, White MC, Sabatino SA, de Moor J, Doria-Rose PV, et al. Cancer screening test use - United States, 2015. MMWR Morb Mortal Wkly Rep2017;66:201–6.
23. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER cancer statistics review, 1975–2012. Bethesda, MD: National Cancer Institute; 2015.
24. Bain C, Speizer FE, Rosner B, Belanger C, Hennekens CH. Family history of breast cancer as a risk indicator for the disease. Am J Epidemiol 1980;111: 301–8.
25. Brinton LA, Hoover R, Fraumeni JF Jr. Interaction of familial and hormonal risk factors for breast cancer. J Nat Cancer Inst 1982;69:817–22.
26. Egan KM, Stampfer MJ, Rosner BA, Trichopoulos D, Newcomb PA, Trentham-Dietz A, et al. Risk factors for breast cancer in women with a breast cancer family history. Cancer Epidemiol Biomarkers Prev 1998;7: 359–64.
27. Sellers TA, Kushi LH, Potter JD, Kaye SA, Nelson CL, McGovern PG, et al. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Eng J Med 1992;326: 1323–9.
28. Colditz GA, Kaphingst KA, Hankinson SE, Rosner B. Family history and risk of breast cancer: nurses' health study. Breast Cancer Res Treat 2012;133: 1097–104.
29. CDC/National Center for Health Statistics. About the national health interview survey [Internet]. Atlanta, GA: CDC/National Center for Health Statistics; 2015. Available from: http://www.cdc.gov/nchs/nhis/about_nhis.htm
30. Lynch HT, Guirgis HA, Albert S, Brennan M, Lynch J, Kraft C, et al. Familial association of carcinoma of the breast and ovary. Surg Gynecol Obst 1974;138:717–24.
31. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378:789–92.
32. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66–71.
33. Claus EB, Schildkraut J, Iversen ES Jr., Berry D, Parmigiani G. Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history. J Nat Cancer Inst 1998;90:1824–9.
34. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003;302:643–6.
35. Malone KE, Daling JR, Doody DR, Hsu L, Bernstein L, Coates RJ, et al. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 2006;66:8297–308.
36. US Census Bureau. Historical households tables: Table HH-6. Average population per household and family: 1940 to present [Internet]. Suitland, MD: US Department of Commerce, November 2016. Available from: https://www.census.gov/data/tables/time-series/demo/families/households.html.
37. National Center for Health Statistics. Vital statistics of the United States, 2003, Vol. I. Hyattsville, MD: Centers for Disease Control and Prevention; 2005.
38. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997;71:800–9.
39. Molino A, Giovannini M, Pedersini R, Frisinghelli M, Micciolo R, Mandara M, et al. Correlations between family history and cancer characteristics in 2256 breast cancer patients. Br J Cancer 2004;91:96–8.
40. Malone KE, Daling JR, Doody DR, O'Brien C, Resler A, Ostrander EA, et al. Family history of breast cancer in relation to tumor characteristics and mortality in a population-based study of young women with invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2011;20:2560–71.
41. Melvin JC, Wulaningsih W, Hana Z, Purushotham AD, Pinder SE, Fentiman I, et al. Family history of breast cancer and its association with disease severity and mortality. Cancer Med 2016;5:942–9.
42. Wobbes T, van de Wiel MP, van der Sluis RF, Theeuwes AG. The effect of familiality on clinical presentation and survival in mammary carcinoma. Eur J Surg Oncol 1987;13:119–21.
43. Crispo A, Barba M, D'Aiuto G, De Laurentiis M, Grimaldi M, Rinaldo M, et al. Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series. BMC Cancer 2013;13:15.
44. Walter LC, Lindquist K, Covinsky KE. Relationship between health status and use of screening mammography and Papanicolaou smears among women older than 70 years of age. Ann Int Med 2004;140:681–8.
45. Tracy KA, Quillin JM, Wilson DB, Borzelleca J, Jones RM, McClish D, et al. The impact of family history of breast cancer and cancer death on women's mammography practices and beliefs. Genet Med 2008;10:621–5.
46. Murabito JM, Evans JC, Larson MG, Kreger BE, Splansky GL, Freund KM, et al. Family breast cancer history and mammography: Framingham Offspring Study. Am J Epidemiol 2001;154:916–23.
47. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, M W. The benefits and harms of breast cancer screening: an independent review. Lancet 2012;380:1778–86.
48. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012;367:1998–2005.
49. Duffy SW, Agbaje O, Tabar L, Vitak B, Bjurstam N, Bjorneld L, et al. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res 2005;7:258–65.
50. Baines CJ, To T, Miller AB. Revised estimates of overdiagnosis from the Canadian National Breast Screening Study. Prev Med 2016;90:66–71.
51. Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol 2007;8: 1129–38.
52. Murff HJ, Peterson NB, Greevy R, Zheng W. Impact of patient age on family cancer history. Gen Med 2006;8:438–42.
53. Chang ET, Smedby KE, Hjalgrim H, Glimelius B, Adami HO. Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Nat Cancer Inst 2006;98:61–8.
54. Kerber RA, Slattery ML. Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 1997;146:244–8.